Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Expert Review of Hematology · Published 2026-08-05 · DOI 10.1080/17474086.2026.2715442

Authors (5)

Bartosz Puła, Wiktoria Ryżewska, Artur Handziuk, Agata Tyczyńska, Tadeusz Kubicki

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Puła, B., Ryżewska, W., Handziuk, A., et al. (2026). Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?. Expert Review of Hematology. https://doi.org/10.1080/17474086.2026.2715442

Related articles

• Identifying High-Risk Smoldering Multiple Myeloma for Early Intervention · JAMA Oncology · 2026 · Cites or is cited by this article
• Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think? · Expert Review of Hematology · 2026 · Same journal
• Challenges faced by women and girls with hemophilia/Carriers: an expert call for closing the diagnosis gap · Expert Review of Hematology · 2026 · Same journal
• Social challenges and support needs of patients with hemophilia in Pakistan: a qualitative exploratory study · Expert Review of Hematology · 2026 · Same journal
• Autoimmune cytopenias in chronic lymphocytic leukemia in the era of novel drugs · Expert Review of Hematology · 2026 · Same journal
• A Review of Disparities in Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma · Expert Review of Hematology · 2026 · Same journal
• Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison · Expert Review of Hematology · 2026 · Same journal
• An interview with Dr Joshua Richter on his experience as an investigator for linvoseltamab-gcpt - by Reegan Burnell-Clarke (Commissioning Editor) · Expert Review of Hematology · 2026 · Same journal
• Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timing · Expert Review of Hematology · 2026 · Same journal
• Apparent plateaus during iron chelation in transfusion-dependent β-thalassemia: interpretation and clinical implications · Expert Review of Hematology · 2026 · Same journal